Division of Cardiology, Department of Medicine, Medical University of Graz, 8036 Graz, Austria.
Sensors (Basel). 2021 Dec 21;22(1):22. doi: 10.3390/s22010022.
A wearable cardioverter-defibrillator (WCD) is a temporary treatment option for patients at high risk for sudden cardiac death (SCD) and for patients who are temporarily not candidates for an implantable cardioverter defibrillator (ICD). In addition, the need for telemedical concepts in the detection and treatment of heart failure (HF) and its arrhythmias is growing. The WCD has evolved from a shock device detecting malignant ventricular arrhythmias (VA) and treating them with shocks to a heart-failure-monitoring device that captures physical activity and cardioacoustic biomarkers as surrogate parameters for HF to help the treating physician surveil and guide the HF therapy of each individual patient. In addition to its important role in preventing SCD, the WCD could become an important tool in heart failure treatment by helping prevent HF events by detecting imminent decompensation via remote monitoring and monitoring therapy success.
可穿戴式心脏除颤器（WCD）是一种针对高危心源性猝死（SCD）患者和暂时不适合植入式心脏除颤器（ICD）患者的临时治疗选择。此外，远程医疗概念在心力衰竭（HF）及其心律失常的检测和治疗中的应用需求正在不断增长。WCD 已经从一个检测恶性室性心律失常（VA）并通过电击进行治疗的电击设备演变为一种心力衰竭监测设备，它可以捕捉身体活动和心音生物标志物作为心力衰竭的替代参数，以帮助治疗医生监测和指导每个患者的心力衰竭治疗。除了在预防 SCD 方面的重要作用外，WCD 还可以通过远程监测和监测治疗效果来检测即将发生的失代偿情况，从而帮助预防 HF 事件，成为心力衰竭治疗的重要工具。
